Scientific Advisory Board (SAB)

The Scientific Advisory Board plays a major role in the process for reviewing and selecting ELIXIR Nodes and provides strategic scientific advice to the ELIXIR Board. The SAB is an independent body, made up of leading experts from around the world. The committee also includes two independent ethics advisors to advise on ethical, legal and social issues related to ELIXIR. The ELIXIR SAB meets twice a year. 

What the SAB does

  • Reviews applications for new Nodes and makes recommendations to the ELIXIR Board
  • Ensures scientific and technical excellence and relevance (including independent quality assurance)
  • Identifies and recommends emerging challenges and opportunities, both within and beyond ELIXIR activities (including specific periodic reviews)
  • Carries out periodic scientific reviews of ELIXIR Platforms and Use Cases
  • Reports directly to the ELIXIR Board and ELIXIR Director on the results of their scientific reviews of ELIXIR activities

SAB members

  • Chair: Dr BF Francis Ouellette    
  • Vice Chair: Dr Janet Kelso
Name Affiliation
Prof. Pascal Borry University of Leuven, Belgium
Dr Robert Gentleman 23andMe, USA
Prof. Melissa Haendel Oregon Health and Science University, USA
Prof. Larry Hunter University of Colorado, USA
Prof. Elina Ikonen University of Helsinki, Finland
Dr Janet Kelso (Vice Chair) Max Planck Institute for Evolutionary Anthropology, Germany
Prof. Nicola Mulder UCT Computational Biology Group (NBN), South Africa
Dr BF Francis Ouellette (Chair) Origin Bioinformatics, Canada
Prof. Juni Palmgren Karolinska Institutet, Sweden
Dr Susan E. Wallace University of Leceister, UK
Dr Doreen Ware USDA ARS, Cold Spring Harbor Laboratory, USA
Scientific Advisory Board members
Members of the SAB (from left to right): Janet Kelso, Larry Hunter, Francis Ouelette, Robert Gentleman, Nicola Mulder, Elina Ikonen and Juni Palmgren, (not pictured: Jérôme Wojcik, Susan E. Wallace, Pascal Borry and Alan Archibald).